Alkem Laboratories (Alkem) is among the largest companies in the Indian formulation market, having a market share of 3.6%. The company is the fifth largest pharmaceutical company in India by domestic sales. Currently, domestic markets constitute around 75% of its sales; while in terms of exports, the company is at a relatively nascent stage vis-a-vis its peers. In exports (predominately US), the company is expanding through both the inorganic and the organic route. Alkem has 16 manufacturing units, 14 in India and 2 in the US; of which, 5 are USFDA, TGA and UK-MHRA approved. Established Market Leadership in Domestic formulation market: Alkem is one of Indias leading pharmaceutical companies in the domestic formulation market Domestic formulations constitute around ~75% of the companys overall sales. The company ranks fifth in the Indian pharmaceutical market. Its most significant therapeutic areas accounted for 80.7% of its total sales in the domestic market in FY2015. Its revenues from domestic operations grew at a CAGR of 17.6% over FY2011 to FY2015. Expanding in export markets: Although a late entrant in the export markets, ~25% of Alkems sales are contributed by exports. The company has expanded internationally through organic growth and through certain strategic acquisitions....